eli lilly phase 3 trial retatrutide THIS is not a small step forward. It's a leap. A new of just dropped from and Company… and the results are genuinely unlike anything we've retatrutide #elililly #retatrutide #weightloss #obesitycare

the need for informed consent was waived due to use of de-identified data

Industry Dynamics The rising geriatric population, which is at a higher risk of developing type 2 diabetes and related health conditions, has led to a greater need for GLP-1 analogues inhibitors

Specific supplements that practitioners commonly recommend alongside GLP-1 microdosing for autoimmune conditions include vitamin D (immune modulator), omega-3 fish oil (anti-inflammatory), and curcumin (NF-kB inhibitor through a complementary pathway)

[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings

The starting dose is now available at more than 70,000 US pharmacies such as CVS and Costco, as well as some telehealth providers including Ro, LifeMD and Weight Watchers

Results develop over weeks to months and vary significantly based on individual gut ecology